Rhumbline Advisers Anavex Life Sciences Corp. Transaction History
Rhumbline Advisers
- $113 Billion
- Q2 2025
A detailed history of Rhumbline Advisers transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Rhumbline Advisers holds 128,370 shares of AVXL stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
128,370
Previous 120,993
6.1%
Holding current value
$1.26 Million
Previous $1.04 Million
13.97%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding AVXL
# of Institutions
197Shares Held
32MCall Options Held
1.16MPut Options Held
804K-
Black Rock Inc. New York, NY6.39MShares$62.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$49.9 Million0.0% of portfolio
-
State Street Corp Boston, MA2.95MShares$28.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.02MShares$19.8 Million0.0% of portfolio
-
Nwam LLC Mercer Island, WA1.02MShares$10 Million0.83% of portfolio
About ANAVEX LIFE SCIENCES CORP.
- Ticker AVXL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,942,800
- Market Cap $762M
- Description
- Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...